Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis
Authors
Keywords
Breast cancer, Brain metastasis, Progesterone receptor negative breast cancer
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-04-25
DOI
10.1186/1471-2407-14-289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics of Breast Cancer Patients with Central Nervous System Metastases: A Single-Center Experience
- (2015) Hakan Harputluoglu et al. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
- (2013) Pia Bükmann Larsen et al. CANCER TREATMENT REVIEWS
- Brain metastases free survival differs between breast cancer subtypes
- (2012) A Berghoff et al. BRITISH JOURNAL OF CANCER
- Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery
- (2012) Tamara Z. Vern-Gross et al. JOURNAL OF NEURO-ONCOLOGY
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: A dosimetric comparison
- (2011) Volker Rudat et al. Radiation Oncology
- Prophylactic cranial irradiation in lung cancer
- (2010) Pierre Blanchard et al. CURRENT OPINION IN ONCOLOGY
- How Long Have I Got? Estimating Typical, Best-Case, and Worst-Case Scenarios for Patients Starting First-Line Chemotherapy for Metastatic Breast Cancer: A Systematic Review of Recent Randomized Trials
- (2010) Belinda E. Kiely et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis
- (2010) Alexander Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- The Effect of Early Detection of Occult Brain Metastases in HER2-Positive Breast Cancer Patients on Survival and Cause of Death
- (2009) Anna Niwińska et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial
- (2009) Cécile Le Péchoux et al. LANCET ONCOLOGY
- A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
- (2008) David Cameron et al. BREAST CANCER RESEARCH AND TREATMENT
- Memory Function Before and After Whole Brain Radiotherapy in Patients With and Without Brain Metastases
- (2008) Grit Welzel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms—Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and Lung Cancer Groups
- (2008) Berend J. Slotman et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis
- (2008) Pinar Saip et al. JOURNAL OF NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search